MedPath

Comparison of two drugs bupivacaine and ropivacaine given in spinal anesthesia in patients undergoing surgery vaginal hysterectomy.

Not Applicable
Conditions
Health Condition 1: N72- Inflammatory disease of cervix uteri
Registration Number
CTRI/2023/06/053746
Lead Sponsor
Dr RPGMC Kangra
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ASA 1 & 2

BMI (18-29.9)

UNDERGOING ELECTIVE VAGINAL HYSTERECTOMY WITH AN ANTICIPATED DURATION OF 120 MINUTES

Exclusion Criteria

REFUSAL TO PARTICIPATE IN STUDY

ALLERGY TO STUDY DRUG

OBESITY (BMI >30)

HEIGHT <150CM OR >180CM

PATIENTS IN WHICH SPACE OTHER THAN L3-L4 WAS USED FOR SUBARACHNOID BLOCK

PATIENTS WITH ABSOLUTE CONTRAINDICATIONS TO SPINAL ANAESTHESIA

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath